Alphatec Holdings, Inc. (ATEC) Stock Price
ATECStock
$10.46−26.65%52W
Market Cap$1.61B
P/E—
PEG Ratio0.48
Div yield—
Beta0.82
ATEC Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-19.11%
Price vs S&P 500 (4W)4.18%
PEG Ratio0.48
VGM Score53.78
ATEC Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $0.07 | $0.07 | +1.30%(+$0.00) | |
| Q1 2026 | -$0.00 | $0.00 | +100.00%(+$0.00) | |
| Q4 2025 | $0.04 | $0.06 | +44.93%(+$0.02) | |
| Q3 2025 | -$0.02 | $0.03 | +233.39%(+$0.05) | |
| Q2 2025 | -$0.04 | $0.02 | +148.00%(+$0.06) |
ATEC Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.11
4.11
4.14
4.14
Industry Peers — Surgical & Medical Instruments(142)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
ATECAlphatec Holdings, Inc. | D | B | C | 2.0x | 39.5% | 70.8% | -7.5% | $10.46 |
| SYKStryker Corporation | C | B | C | 4.4x | 11.8% | 65.3% | 21.3% | $294.66 |
| MMM3M Company | C | D | B | 3.4x | -5.0% | 39.4% | 18.4% | $164.75 |
| BSXBoston Scientific Corp. | C | B | C | 3.1x | 15.2% | 69.5% | 19.8% | $44.39 |
| BDXBecton, Dickinson and Co. | B | D | A | 2.5x | 6.3% | 46.7% | 9.6% | $191.75 |
| MDLNMedline Inc. Class A common stock | C | D | C | 1.6x | — | 26.2% | 6.0% | $35.96 |
| RMDResMed Inc. | C | C | B | 5.9x | 12.1% | 61.1% | 33.4% | $238.97 |
| DXCMDexCom, Inc. | C | B | B | 6.5x | 19.3% | 64.3% | 22.9% | $86.04 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | 8.5x | 7.4% | 36.8% | 20.4% | $384.02 |
| SOLVSolventum Corporation | C | C | B | 1.8x | — | 54.8% | 23.9% | $85.81 |
| BAXBaxter International Inc. | B | D | B | 1.1x | -0.8% | 30.7% | -2.3% | $25.28 |
About Alphatec Holdings, Inc.
Alphatec Holdings is a medical technology company that develops spine surgery solutions for treating degenerative disc disease, spinal trauma, and congenital deformities. The company offers a portfolio of implants and surgical instruments across multiple fusion approaches—including anterior cervical, lateral interbody, and posterior lumbar procedures—designed to decompress nerves, stabilize the spine, and restore proper alignment. Its diverse product platform addresses a large and growing market for spinal surgery treatments.